Funding Organization: National Institutes of Health (NIH)
Total Funding Amount: Up to $475,000 per year
Duration: Maximum project period of 4 years
Primary Objective: Enable translation of nanotechnology-based cancer interventions
Key Stakeholders: National Cancer Institute (NCI), researchers in nanotechnology and oncology
Funding Source: Federal government
Significance: Aims to improve cancer treatment effectiveness through innovative nanotechnology
Grant Frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Governments
Eligible Agencies of the Federal Government
U.S. Territory or Possession
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Faith-based or Community-based Organizations
Regional Organizations
Non-domestic (non-U.S.) Entities are not eligible to apply.
Non-domestic components of U.S. Organizations are not eligible to apply.
Combination Therapy
Immunotherapy
Imaging and Diagnostics
Projects should mature nanotechnology-based interventions for clinical objectives.
Focus on one or two tumor types.
Projects should incorporate multidisciplinary research in biology/oncology, chemistry, physics, and/or engineering.
Application budgets are limited to $475,000 in direct costs per year.
No cost sharing is required.
Next application due date: May 17, 2027, by 5:00 PM local time.
Must comply with NIH Grants Policy Statement and other federal regulations.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.